Clinical Trial Update: Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study update for CLG561 in patients with age-related macular degeneration; results from the completed trial are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• CLG561

Snippet

Sponsor: Alcon Research | Conditions: Age-related Macular Degeneration | Phase 1 | Status: COMPLETED | Results posted: 2016-03-25